ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Exosome Therapeutics and Diagnostics Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-34Y16629
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Exosome Therapeutics and Diagnostics Market Research Report 2024
BUY CHAPTERS

Global Exosome Therapeutics and Diagnostics Market Research Report 2024

Code: QYRE-Auto-34Y16629
Report
April 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Evox Therapeutics
Carmine Therapeutics
Exopharm
Aruna Bio
Capricor Therapeutics
ReNeuron
Aegle Therapeutics
Sarepta Therapeutics
Codiak BioSciences
Exosomics
Aethlon Medical
ExoCoBio
ORGANICELL
PureTech
Exosome Diagnostics
Mantra Bio
Adipomics
Innocan Pharma
Versatope
Vesvigen Therapeutics
Exosome Plus
ECHO Biaotech

Exosome Therapeutics and Diagnostics Market

Exosomes are small vesicles secreted by cells, which contain biomolecules such as proteins, nucleic acids, and lipids. In recent years, exosomes have attracted much attention due to their role in intercellular communication, disease occurrence and development, etc. The application of exosomes in treatment and diagnosis has also gradually attracted attention.
The global Exosome Therapeutics and Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Exosome Therapeutics and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosome Therapeutics and Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Exosome Therapeutics and Diagnostics in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Exosome Therapeutics and Diagnostics include Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, Mantra Bio, Adipomics, ReNeuron, Aegle Therapeutics, Sarepta Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Therapeutics and Diagnostics.
The Exosome Therapeutics and Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Therapeutics and Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Therapeutics and Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Exosome Therapeutics and Diagnostics Market Report

Report Metric Details
Report Name Exosome Therapeutics and Diagnostics Market
Segment by Type
  • Treatment
  • Diagnosis
Segment by Application
  • Cancer
  • Neurological Diseases
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, Mantra Bio, Adipomics, ReNeuron, Aegle Therapeutics, Sarepta Therapeutics, Codiak Biosciences, Exosomics, Innocan Pharma, Aethlon Medical, ExoCoBio, Organicell, Puretech, Versatope, Vesvigen Therapeutics, Exosome Plus, Exosome Diagnostics, ECHO Biaotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Exosome Therapeutics and Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Exosome Therapeutics and Diagnostics Market report?

Ans: The main players in the Exosome Therapeutics and Diagnostics Market are Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, Mantra Bio, Adipomics, ReNeuron, Aegle Therapeutics, Sarepta Therapeutics, Codiak Biosciences, Exosomics, Innocan Pharma, Aethlon Medical, ExoCoBio, Organicell, Puretech, Versatope, Vesvigen Therapeutics, Exosome Plus, Exosome Diagnostics, ECHO Biaotech

What are the Application segmentation covered in the Exosome Therapeutics and Diagnostics Market report?

Ans: The Applications covered in the Exosome Therapeutics and Diagnostics Market report are Cancer, Neurological Diseases, Others

What are the Type segmentation covered in the Exosome Therapeutics and Diagnostics Market report?

Ans: The Types covered in the Exosome Therapeutics and Diagnostics Market report are Treatment, Diagnosis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Treatment
1.2.3 Diagnosis
1.3 Market by Application
1.3.1 Global Exosome Therapeutics and Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Neurological Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapeutics and Diagnostics Market Perspective (2019-2030)
2.2 Global Exosome Therapeutics and Diagnostics Growth Trends by Region
2.2.1 Global Exosome Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Exosome Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Exosome Therapeutics and Diagnostics Market Dynamics
2.3.1 Exosome Therapeutics and Diagnostics Industry Trends
2.3.2 Exosome Therapeutics and Diagnostics Market Drivers
2.3.3 Exosome Therapeutics and Diagnostics Market Challenges
2.3.4 Exosome Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Exosome Therapeutics and Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Exosome Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Exosome Therapeutics and Diagnostics Revenue
3.4 Global Exosome Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Exosome Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapeutics and Diagnostics Revenue in 2023
3.5 Global Key Players of Exosome Therapeutics and Diagnostics Head office and Area Served
3.6 Global Key Players of Exosome Therapeutics and Diagnostics, Product and Application
3.7 Global Key Players of Exosome Therapeutics and Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Exosome Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)
5 Exosome Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Exosome Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Therapeutics and Diagnostics Market Size (2019-2030)
6.2 North America Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
6.4 North America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Therapeutics and Diagnostics Market Size (2019-2030)
7.2 Europe Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.4 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapeutics and Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Exosome Therapeutics and Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Therapeutics and Diagnostics Market Size (2019-2030)
9.2 Latin America Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Exosome Therapeutics and Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Evox Therapeutics
11.1.1 Evox Therapeutics Company Details
11.1.2 Evox Therapeutics Business Overview
11.1.3 Evox Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.1.4 Evox Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.1.5 Evox Therapeutics Recent Development
11.2 Carmine Therapeutics
11.2.1 Carmine Therapeutics Company Details
11.2.2 Carmine Therapeutics Business Overview
11.2.3 Carmine Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.2.4 Carmine Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.2.5 Carmine Therapeutics Recent Development
11.3 Exopharm
11.3.1 Exopharm Company Details
11.3.2 Exopharm Business Overview
11.3.3 Exopharm Exosome Therapeutics and Diagnostics Introduction
11.3.4 Exopharm Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.3.5 Exopharm Recent Development
11.4 Aruna Bio
11.4.1 Aruna Bio Company Details
11.4.2 Aruna Bio Business Overview
11.4.3 Aruna Bio Exosome Therapeutics and Diagnostics Introduction
11.4.4 Aruna Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.4.5 Aruna Bio Recent Development
11.5 Capricor Therapeutics
11.5.1 Capricor Therapeutics Company Details
11.5.2 Capricor Therapeutics Business Overview
11.5.3 Capricor Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.5.4 Capricor Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.5.5 Capricor Therapeutics Recent Development
11.6 Mantra Bio
11.6.1 Mantra Bio Company Details
11.6.2 Mantra Bio Business Overview
11.6.3 Mantra Bio Exosome Therapeutics and Diagnostics Introduction
11.6.4 Mantra Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.6.5 Mantra Bio Recent Development
11.7 Adipomics
11.7.1 Adipomics Company Details
11.7.2 Adipomics Business Overview
11.7.3 Adipomics Exosome Therapeutics and Diagnostics Introduction
11.7.4 Adipomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.7.5 Adipomics Recent Development
11.8 ReNeuron
11.8.1 ReNeuron Company Details
11.8.2 ReNeuron Business Overview
11.8.3 ReNeuron Exosome Therapeutics and Diagnostics Introduction
11.8.4 ReNeuron Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.8.5 ReNeuron Recent Development
11.9 Aegle Therapeutics
11.9.1 Aegle Therapeutics Company Details
11.9.2 Aegle Therapeutics Business Overview
11.9.3 Aegle Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.9.4 Aegle Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.9.5 Aegle Therapeutics Recent Development
11.10 Sarepta Therapeutics
11.10.1 Sarepta Therapeutics Company Details
11.10.2 Sarepta Therapeutics Business Overview
11.10.3 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.10.4 Sarepta Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.10.5 Sarepta Therapeutics Recent Development
11.11 Codiak Biosciences
11.11.1 Codiak Biosciences Company Details
11.11.2 Codiak Biosciences Business Overview
11.11.3 Codiak Biosciences Exosome Therapeutics and Diagnostics Introduction
11.11.4 Codiak Biosciences Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.11.5 Codiak Biosciences Recent Development
11.12 Exosomics
11.12.1 Exosomics Company Details
11.12.2 Exosomics Business Overview
11.12.3 Exosomics Exosome Therapeutics and Diagnostics Introduction
11.12.4 Exosomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.12.5 Exosomics Recent Development
11.13 Innocan Pharma
11.13.1 Innocan Pharma Company Details
11.13.2 Innocan Pharma Business Overview
11.13.3 Innocan Pharma Exosome Therapeutics and Diagnostics Introduction
11.13.4 Innocan Pharma Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.13.5 Innocan Pharma Recent Development
11.14 Aethlon Medical
11.14.1 Aethlon Medical Company Details
11.14.2 Aethlon Medical Business Overview
11.14.3 Aethlon Medical Exosome Therapeutics and Diagnostics Introduction
11.14.4 Aethlon Medical Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.14.5 Aethlon Medical Recent Development
11.15 ExoCoBio
11.15.1 ExoCoBio Company Details
11.15.2 ExoCoBio Business Overview
11.15.3 ExoCoBio Exosome Therapeutics and Diagnostics Introduction
11.15.4 ExoCoBio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.15.5 ExoCoBio Recent Development
11.16 Organicell
11.16.1 Organicell Company Details
11.16.2 Organicell Business Overview
11.16.3 Organicell Exosome Therapeutics and Diagnostics Introduction
11.16.4 Organicell Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.16.5 Organicell Recent Development
11.17 Puretech
11.17.1 Puretech Company Details
11.17.2 Puretech Business Overview
11.17.3 Puretech Exosome Therapeutics and Diagnostics Introduction
11.17.4 Puretech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.17.5 Puretech Recent Development
11.18 Versatope
11.18.1 Versatope Company Details
11.18.2 Versatope Business Overview
11.18.3 Versatope Exosome Therapeutics and Diagnostics Introduction
11.18.4 Versatope Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.18.5 Versatope Recent Development
11.19 Vesvigen Therapeutics
11.19.1 Vesvigen Therapeutics Company Details
11.19.2 Vesvigen Therapeutics Business Overview
11.19.3 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Introduction
11.19.4 Vesvigen Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.19.5 Vesvigen Therapeutics Recent Development
11.20 Exosome Plus
11.20.1 Exosome Plus Company Details
11.20.2 Exosome Plus Business Overview
11.20.3 Exosome Plus Exosome Therapeutics and Diagnostics Introduction
11.20.4 Exosome Plus Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.20.5 Exosome Plus Recent Development
11.21 Exosome Diagnostics
11.21.1 Exosome Diagnostics Company Details
11.21.2 Exosome Diagnostics Business Overview
11.21.3 Exosome Diagnostics Exosome Therapeutics and Diagnostics Introduction
11.21.4 Exosome Diagnostics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.21.5 Exosome Diagnostics Recent Development
11.22 ECHO Biaotech
11.22.1 ECHO Biaotech Company Details
11.22.2 ECHO Biaotech Business Overview
11.22.3 ECHO Biaotech Exosome Therapeutics and Diagnostics Introduction
11.22.4 ECHO Biaotech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
11.22.5 ECHO Biaotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Evox Therapeutics
Carmine Therapeutics
Exopharm
Aruna Bio
Capricor Therapeutics
ReNeuron
Aegle Therapeutics
Sarepta Therapeutics
Codiak BioSciences
Exosomics
Aethlon Medical
ExoCoBio
ORGANICELL
PureTech
Exosome Diagnostics
Mantra Bio
Adipomics
Innocan Pharma
Versatope
Vesvigen Therapeutics
Exosome Plus
ECHO Biaotech
List of Tables
 Table 1. Global Exosome Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Treatment
 Table 3. Key Players of Diagnosis
 Table 4. Global Exosome Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Exosome Therapeutics and Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Exosome Therapeutics and Diagnostics Market Share by Region (2019-2024)
 Table 8. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Exosome Therapeutics and Diagnostics Market Share by Region (2025-2030)
 Table 10. Exosome Therapeutics and Diagnostics Market Trends
 Table 11. Exosome Therapeutics and Diagnostics Market Drivers
 Table 12. Exosome Therapeutics and Diagnostics Market Challenges
 Table 13. Exosome Therapeutics and Diagnostics Market Restraints
 Table 14. Global Exosome Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Exosome Therapeutics and Diagnostics Market Share by Players (2019-2024)
 Table 16. Global Top Exosome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics and Diagnostics as of 2023)
 Table 17. Ranking of Global Top Exosome Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Exosome Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Exosome Therapeutics and Diagnostics, Headquarters and Area Served
 Table 20. Global Key Players of Exosome Therapeutics and Diagnostics, Product and Application
 Table 21. Global Key Players of Exosome Therapeutics and Diagnostics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)
 Table 25. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)
 Table 27. Global Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)
 Table 29. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)
 Table 31. North America Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Exosome Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Evox Therapeutics Company Details
 Table 47. Evox Therapeutics Business Overview
 Table 48. Evox Therapeutics Exosome Therapeutics and Diagnostics Product
 Table 49. Evox Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 50. Evox Therapeutics Recent Development
 Table 51. Carmine Therapeutics Company Details
 Table 52. Carmine Therapeutics Business Overview
 Table 53. Carmine Therapeutics Exosome Therapeutics and Diagnostics Product
 Table 54. Carmine Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 55. Carmine Therapeutics Recent Development
 Table 56. Exopharm Company Details
 Table 57. Exopharm Business Overview
 Table 58. Exopharm Exosome Therapeutics and Diagnostics Product
 Table 59. Exopharm Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 60. Exopharm Recent Development
 Table 61. Aruna Bio Company Details
 Table 62. Aruna Bio Business Overview
 Table 63. Aruna Bio Exosome Therapeutics and Diagnostics Product
 Table 64. Aruna Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 65. Aruna Bio Recent Development
 Table 66. Capricor Therapeutics Company Details
 Table 67. Capricor Therapeutics Business Overview
 Table 68. Capricor Therapeutics Exosome Therapeutics and Diagnostics Product
 Table 69. Capricor Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 70. Capricor Therapeutics Recent Development
 Table 71. Mantra Bio Company Details
 Table 72. Mantra Bio Business Overview
 Table 73. Mantra Bio Exosome Therapeutics and Diagnostics Product
 Table 74. Mantra Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 75. Mantra Bio Recent Development
 Table 76. Adipomics Company Details
 Table 77. Adipomics Business Overview
 Table 78. Adipomics Exosome Therapeutics and Diagnostics Product
 Table 79. Adipomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 80. Adipomics Recent Development
 Table 81. ReNeuron Company Details
 Table 82. ReNeuron Business Overview
 Table 83. ReNeuron Exosome Therapeutics and Diagnostics Product
 Table 84. ReNeuron Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 85. ReNeuron Recent Development
 Table 86. Aegle Therapeutics Company Details
 Table 87. Aegle Therapeutics Business Overview
 Table 88. Aegle Therapeutics Exosome Therapeutics and Diagnostics Product
 Table 89. Aegle Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 90. Aegle Therapeutics Recent Development
 Table 91. Sarepta Therapeutics Company Details
 Table 92. Sarepta Therapeutics Business Overview
 Table 93. Sarepta Therapeutics Exosome Therapeutics and Diagnostics Product
 Table 94. Sarepta Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 95. Sarepta Therapeutics Recent Development
 Table 96. Codiak Biosciences Company Details
 Table 97. Codiak Biosciences Business Overview
 Table 98. Codiak Biosciences Exosome Therapeutics and Diagnostics Product
 Table 99. Codiak Biosciences Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 100. Codiak Biosciences Recent Development
 Table 101. Exosomics Company Details
 Table 102. Exosomics Business Overview
 Table 103. Exosomics Exosome Therapeutics and Diagnostics Product
 Table 104. Exosomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 105. Exosomics Recent Development
 Table 106. Innocan Pharma Company Details
 Table 107. Innocan Pharma Business Overview
 Table 108. Innocan Pharma Exosome Therapeutics and Diagnostics Product
 Table 109. Innocan Pharma Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 110. Innocan Pharma Recent Development
 Table 111. Aethlon Medical Company Details
 Table 112. Aethlon Medical Business Overview
 Table 113. Aethlon Medical Exosome Therapeutics and Diagnostics Product
 Table 114. Aethlon Medical Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 115. Aethlon Medical Recent Development
 Table 116. ExoCoBio Company Details
 Table 117. ExoCoBio Business Overview
 Table 118. ExoCoBio Exosome Therapeutics and Diagnostics Product
 Table 119. ExoCoBio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 120. ExoCoBio Recent Development
 Table 121. Organicell Company Details
 Table 122. Organicell Business Overview
 Table 123. Organicell Exosome Therapeutics and Diagnostics Product
 Table 124. Organicell Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 125. Organicell Recent Development
 Table 126. Puretech Company Details
 Table 127. Puretech Business Overview
 Table 128. Puretech Exosome Therapeutics and Diagnostics Product
 Table 129. Puretech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 130. Puretech Recent Development
 Table 131. Versatope Company Details
 Table 132. Versatope Business Overview
 Table 133. Versatope Exosome Therapeutics and Diagnostics Product
 Table 134. Versatope Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 135. Versatope Recent Development
 Table 136. Vesvigen Therapeutics Company Details
 Table 137. Vesvigen Therapeutics Business Overview
 Table 138. Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Product
 Table 139. Vesvigen Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 140. Vesvigen Therapeutics Recent Development
 Table 141. Exosome Plus Company Details
 Table 142. Exosome Plus Business Overview
 Table 143. Exosome Plus Exosome Therapeutics and Diagnostics Product
 Table 144. Exosome Plus Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 145. Exosome Plus Recent Development
 Table 146. Exosome Diagnostics Company Details
 Table 147. Exosome Diagnostics Business Overview
 Table 148. Exosome Diagnostics Exosome Therapeutics and Diagnostics Product
 Table 149. Exosome Diagnostics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 150. Exosome Diagnostics Recent Development
 Table 151. ECHO Biaotech Company Details
 Table 152. ECHO Biaotech Business Overview
 Table 153. ECHO Biaotech Exosome Therapeutics and Diagnostics Product
 Table 154. ECHO Biaotech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)
 Table 155. ECHO Biaotech Recent Development
 Table 156. Research Programs/Design for This Report
 Table 157. Key Data Information from Secondary Sources
 Table 158. Key Data Information from Primary Sources
 Table 159. Authors List of This Report


List of Figures
 Figure 1. Exosome Therapeutics and Diagnostics Picture
 Figure 2. Global Exosome Therapeutics and Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Exosome Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030
 Figure 4. Treatment Features
 Figure 5. Diagnosis Features
 Figure 6. Global Exosome Therapeutics and Diagnostics Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Exosome Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030
 Figure 8. Cancer Case Studies
 Figure 9. Neurological Diseases Case Studies
 Figure 10. Others Case Studies
 Figure 11. Exosome Therapeutics and Diagnostics Report Years Considered
 Figure 12. Global Exosome Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global Exosome Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Exosome Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030
 Figure 15. Global Exosome Therapeutics and Diagnostics Market Share by Players in 2023
 Figure 16. Global Top Exosome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics and Diagnostics as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by Exosome Therapeutics and Diagnostics Revenue in 2023
 Figure 18. North America Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)
 Figure 20. United States Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)
 Figure 24. Germany Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Exosome Therapeutics and Diagnostics Market Share by Region (2019-2030)
 Figure 32. China Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)
 Figure 40. Mexico Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)
 Figure 44. Turkey Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Evox Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 48. Carmine Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 49. Exopharm Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 50. Aruna Bio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 51. Capricor Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 52. Mantra Bio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 53. Adipomics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 54. ReNeuron Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 55. Aegle Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 56. Sarepta Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 57. Codiak Biosciences Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 58. Exosomics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 59. Innocan Pharma Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 60. Aethlon Medical Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 61. ExoCoBio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 62. Organicell Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 63. Puretech Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 64. Versatope Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 65. Vesvigen Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 66. Exosome Plus Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 67. Exosome Diagnostics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 68. ECHO Biaotech Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Exosome Detection and Diagnosis Market Research Report 2024
Global Exosome Diagnostic and Therapeutic Market Insights Forecast to 2030
Global Exosome Technology Services Market Research Report 2025
Global Exosome Research Market Research Report 2024
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Research Report 2025
Global Medicinal Exosomes Market Research Report 2024
Diagnostic Exosome Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Extracellular Vesicle Therapy Market Research Report 2024
Global Exosome Therapeutics Market Research Report 2024
Global Exosome Manufacturing Service Market Research Report 2024
Global Exosome Therapy Technology Market Research Report 2025
Global Exosome Rapid Molecular Detection Market Research Report 2024
Global Exosomes Skincare Market Research Report 2025
Global Plant Exosomes Market Research Report 2025
Global Exosome Technologies Market Research Report 2025
Global Exosome Isolation Kits Market Research Report 2025
Global Milk Exosomes Market Research Report 2024
Global Exosome Service Market Research Report 2025
Global Exosome Therapy Market Research Report 2025
Global Exosome Medical Technology Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions